Isabel Vogler
BioNTech (Germany)(DE)
Publications by Year
Research Areas
Immunotherapy and Immune Responses, SARS-CoV-2 and COVID-19 Research, Cancer Immunotherapy and Biomarkers, Immune Cell Function and Interaction, COVID-19 Clinical Research Studies
Most-Cited Works
- → Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer(2017)2,387 cited
- → COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses(2020)2,020 cited
- → An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma(2020)972 cited
- → BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans(2021)818 cited
- → A vaccine targeting mutant IDH1 induces antitumour immunity(2014)690 cited
- → Omicron BA.1 breakthrough infection drives cross-variant neutralization and memory B cell formation against conserved epitopes(2022)218 cited
- → BNT162b2 induces SARS-CoV-2-neutralising antibodies and T cells in humans(2020)171 cited
- → Concurrent human antibody and T H 1 type T-cell responses elicited by a COVID-19 RNA vaccine(2020)67 cited
- → An Improved Bicistronic CD20/tCD34 Vector for Efficient Purification and In Vivo Depletion of Gene-Modified T Cells for Adoptive Immunotherapy(2010)65 cited
- → Accurate detection of tumor-specific gene fusions reveals strongly immunogenic personal neo-antigens(2022)53 cited